Synthesis,biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents |
| |
Authors: | Konstantina Karypidou Sergio R. Ribone Mario A. Quevedo Leentje Persoons Christophe Pannecouque Christine Helsen Frank Claessens Wim Dehaen |
| |
Affiliation: | 1. Molecular Design and Synthesis, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Leuven, Belgium;2. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA, CONICET), Dpto. Farmacia, Fac. Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba X5000HUA, Argentina;3. Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium;4. Laboratory of Molecular Endocrinology, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium |
| |
Abstract: | ![]() Synthesis and biological evaluation of a novel library of fused 1,2,3-triazole derivatives are described. The in-house developed multicomponent reaction based on commercially available starting materials was applied and broad biological screening against various viruses was performed, showing promising antiviral properties for compounds 14d, 14n, 14q, 18f and 18i against human coronavirus 229E. Further in silico studies identified the key molecular interactions between those compounds and the 3-chymotrypsin-like protease, which is essential to the intracellular replication of the virus, supporting the hypothesis that the protease is the target molecule of the potential antiviral derivatives. |
| |
Keywords: | Respiratory syndrome Coronavirus 3CL protease 1,2,3-triazole Biological evaluation |
本文献已被 ScienceDirect 等数据库收录! |
|